Stocks or commodities? David Chalupnik, head of equities at First American Funds, told investors where they should be looking.
Camden Fine, CEO of the Independent Community Bankers of America, said the 1,200 to 1,500 community banks that deal directly with agriculture could be the next to struggle, due to inflated commodities and farmland prices.
Investors are keeping their eyes on earnings and Dow 10,000—so what does it mean for your portfolio and how should you be positioning yourself right now? Jim Lacamp, portfolio manager and advisor at Macroportfolio Advisors and Craig Peckham, equity trading strategist at Jefferies & Co. weighed in.
Tom Forester, portfolio manager of the 5-star Morningstar rated Forester Value Fund, shared his investment strategy and stock picks.
Dow component Johnson & Johnson—the first major health care company to report earnings this quarter—posted weaker-than-expected quarterly revenue on Tuesday. Mike Weinstein, managing director and senior medical technology analyst at JPMorgan, offered his analysis of JNJ.
Stocks fell on Tuesday after the Dow closed near the 10,000 mark on Monday. What is the best move for investors now? Roy Williams, CEO of Prestige Wealth Management, and Bill Smead, CEO and CIO of Smead Capital Management, shared their investment insights.
The XLF financial exchange-traded fund lit up our screens with large upside activity yesterday ahead of major earnings reports this week.
Shares of Goldman Sachs were cut to "neutral" from "buy" by Meredith Whitney Advisory Group, published reports said Tuesday.
Markets traded higher on Monday as better-than-expected earnings results began trickling in, boosting investors' optimism about the overall earnings season. Leo Grohowski, CIO of BNY Mellon Wealth Management, and Charles Kantor, managing director and portfolio manager at Neuberger Berman, shared their market insights.
Anticipation is building over a trio of important tech earnings. This week IBM, Intel and Google release third quarter results, providing what could be a critical view on whether the economic rebound has taken root both in the U.S. and around the world.
The Dow crossed the 9,900 mark on Monday and investors are wondering what the shape of the recovery will look like—will it be a V or a W? Wayne Angell, principal at Angell Economics and former Federal Reserve governor, and Brian Bethune, U.S. economist at IHS Global Insight, shared their market insights.
Jerry Castellini, president and CIO of CastleArk Management, Brian Dolan, chief currency strategist at Forex.com and Matt Zeman, trader at LaSalle Futures Group offered their views on where investors should put their money.
The market has risen so far ahead of the economy, it's hard for Art Cashin, financial services director of floor operations at UBS, to get on board.
This is the week the market will make its big push, as positive earnings surprises will send it higher and carry it through the rest of the year, said Marc Pado, US markets strategist at Cantor Fitzgerald.
A busy week of earnings lies ahead for large financial companies. So what kind of results should investors be expecting? Christopher Whalen, senior vice president and managing director at Institutional Risk Analytics and Paul Miller, group head of financial services at FBR Capital Markets shared their insights.
Oil and gas drillers are the most attractive subsectors within the energy industry now, said Derek Rollingson, portfolio manager at ICON Equity Funds. He shared his top five stock recommendations.
Gold prices rose above $1,050 an ounce on Monday as the dollar turned lower against the euro. Dennis Gartman, founder and editor of The Gartman Letter, shared his outlook on gold prices and currencies.
Synopsys ended last week at its highest closing price in a year, and option traders apparently believe that the chip software company will climb even higher before Christmas.
The global recovery is being led by countries outside of the United States, and investors should look to multinational corporations to protect themselves against the weakening dollar, said David Darst of Morgan Stanley Smith Barney.
Worries over health care reform have caused the sector to be underowned, but there are still opportunities for investors looking to take advantage of the low prices, said Charles Boorady of Citigroup and Arthur Henderson of Jeffries & Co.